# TriSalus Life Sciences, Inc.: Form SCHEDULE 13D/A, filed Dec 19, 2024

- Company: [TriSalus Life Sciences, Inc.](/companies/tlsi.md) (CIK 1826667)
- Form: SCHEDULE 13D/A
- Filed: 2024-12-19
- Accepted by EDGAR: Dec 19, 2024, 21:12 ET
- Period: not reported
- Accession: 0001415889-24-029847
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1826667/000141588924029847/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1826667/000141588924029847/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1826667/000141588924029847/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Dec 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001415889-24-029847. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.